SCHEMBL14083587

SCHEMBL14083587

COc1ccccc1NC(=O)c1ccc(-c2ncccc2Cl)cc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ KMT2A Q03164 3/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ POLB P06746 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ GRM4 Q14833 1/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ CASP3 P42574 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ SENP8 Q96LD8 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49
▸ SENP6 Q9GZR1 1/20 0.49
▸ ABCB1 P08183 3/20 0.48
▸ ABCC1 P33527 1/20 0.48
▸ RORC P51449 1/20 0.47
▸ IRAK4 Q9NWZ3 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083593 0.88 TRPV1 (0.52) KMT2AGRM4MEN1TRPV1
SCHEMBL14108062 0.85 HDAC1 (0.52) KMT2AGRM4RORCMEN1TRPV1
SCHEMBL14083582 0.85 TRPV1 (0.49) RAB9AL3MBTL1KMT2AKDM4EGAA
SCHEMBL14083621 0.85 RAB9A (0.53) RAB9AKMT2APOLBMAPTNPC1
SCHEMBL14083594 0.85 NPC1 (0.63) ALDH1A1RAB9AKMT2AKDM4EMAPT
SCHEMBL14083598 0.84 GAA (0.52) RAB9AKMT2APOLBMAPTGAA
SCHEMBL14082738 0.83 MAPK8 (0.56) ALDH1A1KMT2AKDM4EPOLBMAPT
SCHEMBL14083590 0.83 RAB9A (0.57) ALDH1A1RAB9AKMT2AKDM4EPOLB
SCHEMBL14083476 0.83 KMT2A (0.59) ALDH1A1RAB9AL3MBTL1KMT2APOLB
SCHEMBL14083573 0.82 TRPV1 (0.57) ALDH1A1RAB9AL3MBTL1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 ALDH1A1 1577/4885RAB9A 1914/4885L3MBTL1 3122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback